News on Medial

Related News

SilverPush growth stalls in FY25; slips into red with Rs 18 Cr loss

EntrackrEntrackr · 19d ago
SilverPush growth stalls in FY25; slips into red with Rs 18 Cr loss
Medial

SilverPush couldn’t replicate its FY24 growth momentum in FY25, with revenue posting barely double-digit growth compared to nearly 120% year-on-year growth in FY24. Importantly, the company reported a loss of over Rs 17 crore in 2025. Marketing technology platform SilverPush couldn’t replicate its FY24 growth momentum in FY25, with revenue posting barely double-digit growth compared to nearly 120% year-on-year growth in the previous fiscal (FY24). Importantly, the company slipped into the red, reporting a loss of over Rs 17 crore in the fiscal year ending March 2025. SilverPush’s revenue increased 11% to Rs 386 crore in FY25, as compared to Rs 347 crore in FY24, according to the company's provisional financial statement reviewed by Entrackr. Silverpush provides AI-powered advertising solutions including contextual advertising, audience targeting, and ad measurement solutions. It also allows businesses to track the performance of their ads. The firm hasn’t given its revenue break up across business segments and geographies. On the expense side, cost of sales which includes cloud infrastructure, data and media costs accounted for 63% of the total expense at Rs 233 crore in FY25. Employee benefit expense accounted for 21% of the total expense at Rs 77 crore in FY25. Other expenses such as finance cost, depreciation and other operating expenses contributed another Rs 58 crore. Overall, the company’s total expense stood at Rs 368 crore in FY25. Unlike FY24, when the firm posted a profit of Rs 6 crore, SilverPush slipped into the red, recording a loss of Rs 17.6 crore in FY25. Its EBITDA stood at -Rs 9.45 crore with an EBITDA margin of -2.5%. The Gurugram-based company reported current assets worth Rs 175 crore at the end of FY25 (March 2025), including Rs 49 crore in cash and bank balances. According to the filings, the firm is projected to cross the Rs 500 crore revenue mark in FY26 while regaining profitability of around Rs 19 crore. While that may yet happen, there is little doubt that digital advertising is facing a moment of truth. Be it AI cutting into page views of sites and apps, or more and more sophisticated ways to skip ads, firms are approaching the medium in a whole new way. Including cutting back when they don't sense a receptive market. At the premium end, e-commerce sites are shaving off significant advertising budgets as well, leaving firms like Silver push with a tough market. Though its focus on video is supposed to insulate it somewhat, the segment does have intense competition that will keep eating away margins. The recent GST cuts might just provide Silver push the fillip it needed to get back into the black, but keep an eye on the growth numbers going forward.

Redcliffe Labs posts Rs 419 Cr revenue in FY25; narrows EBITDA losses

EntrackrEntrackr · 3m ago
Redcliffe Labs posts Rs 419 Cr revenue in FY25; narrows EBITDA losses
Medial

Redcliffe Labs posts Rs 419 Cr revenue in FY25; narrows EBITDA losses Diagnostics platform Redcliffe Labs has posted a 20% increase in its operating revenue to Rs 419 crore in FY25 from Rs 350 crore in FY24 and managed to narrow its EBITDA losses, as per the company’s press release. Diagnostics platform Redcliffe Labs has posted a 20% increase in its operating revenue to Rs 419 crore in FY25 from Rs 350 crore in FY24, as per the company’s press release. The Gurugram-based firm also managed to reduce its EBITDA losses from -38% to -21% during the same period. Founded by Aditya Kandoi, Redcliffe operates a nationwide network of over 80 labs and claims to have the widest home sample collection footprint in the country. Diagnostic services contributed over 95% of the company’s revenue in FY25, with the rest coming from product sales and other operating income. The company said it diagnosed over 2.5 million cases last fiscal and continues to focus on expanding in underserved regions, with more than 70% of its testing volumes now coming from Tier II cities and beyond. On the profitability front, Redcliffe reported a gross margin of 70% in FY25 and is aiming to expand it to 74% in FY26. It has also set a revenue target of Rs 560 crore for the ongoing fiscal through organic growth and strategic acquisitions. “We are transforming lives and making diagnostics a first-line solution for millions who were previously underserved,” said Kandoi. The company plans to expand its presence to over 300 cities with 150 labs by FY28. According to startup data platform TheKredible, Redcliffe has raised $113 million to date, including a $42 million Series C round led by LeapFrog. It also acquired Bengaluru-based Celara Diagnostics in a $7 million deal. Redcliffe competes with players like PharmEasy-owned Thyrocare, Tata 1mg, and Healthians.

Download the medial app to read full posts, comements and news.